0001354457-18-000523.txt : 20181212
0001354457-18-000523.hdr.sgml : 20181212
20181212164040
ACCESSION NUMBER: 0001354457-18-000523
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20181212
DATE AS OF CHANGE: 20181212
EFFECTIVENESS DATE: 20181212
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 181231250
BUSINESS ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-466-3500
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: The Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
The Nasdaq Stock Market LLC
0001114220
KERYX BIOPHARMACEUTICALS INC
000-30929
750 Lexington Avenue
New York
NY
NEW YORK
10022
212 531-5965
Common Stock
17 CFR 240.12d2-2(a)(3)
Tara Petta
Director
2018-12-12
EX-99.25
2
kerx-form25.txt
kerx-form25